Cochrane Abstracts
High‐flux versus low‐flux membranes for end‐stage kidney disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"High‐flux Versus Low‐flux Membranes for End‐stage Kidney Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438004/all/High‐flux_versus_low‐flux_membranes_for_end‐stage_kidney_disease.
High‐flux versus low‐flux membranes for end‐stage kidney disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438004/all/High‐flux_versus_low‐flux_membranes_for_end‐stage_kidney_disease. Accessed March 21, 2025.
High‐flux versus low‐flux membranes for end‐stage kidney disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438004/all/High‐flux_versus_low‐flux_membranes_for_end‐stage_kidney_disease
High‐flux Versus Low‐flux Membranes for End‐stage Kidney Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438004/all/High‐flux_versus_low‐flux_membranes_for_end‐stage_kidney_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - High‐flux versus low‐flux membranes for end‐stage kidney disease
ID - 438004
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438004/all/High‐flux_versus_low‐flux_membranes_for_end‐stage_kidney_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
